Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma

British Journal of Cancer

Volumn 82, Issue 4, 2000, Pages 852-857

  Lin, P ^a   Wang, S L ^a   Wang, H J ^a   Chen, K W ^a   Lee, H S ^a   Tsai, K J ^b   Chen, C Y ^c   Lee, H ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Chung Shan University Hospital   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cytochrome P4501A1; Genetic polymorphism; Lung squamous cell carcinoma; Microsomal epoxide hydrolase; Taiwan

Indexed keywords

CYTOCHROME P450; EPOXIDE HYDROLASE; MICROSOME ENZYME;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; DNA PRIMERS; EPOXIDE HYDROLASES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICROSOMES; POLYMORPHISM, GENETIC;

EID: 0033975532     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1011     Document Type: Article

References (43)

1. Bartseh H, Petruzzelli S, De Flora S, Hictanen E, Camus A-M, Castegnaro M, Alexandrov K, Rojas M, Saracci R and Giuntini C (1992) Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: Results from a case-control multicenter study on lung cancer patients. Environ Health Perspect 98: 119-124
2. Benhamou S, Reinikainen M, Bouchardy C, Dayer P and Hirvonen A (1998) Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 58: 5291-5293
3. Binkova B, Lewtas J, Miskova I, Lenicek J and Sram R (1995) DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population. Carcinogenesis 16: 1037-1046
4. Cascorbi I, Brockmoller J and Roots I (1996) A C4887A polymophism in exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact lung cancer susceptibility. Cancer Res 56: 4965-4969
5. Coultas DB and Samet JM (1992) Occupational lung cancer. Clin Chest Med 13: 341-354
6. Daly AK, Cholerton S, Armstrong M and Idle J R (1994) Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 102 (Suppl. 9): 55-61
7. Denison MS and Whitlock JP Jr (1995) Xenobiotic-inducible transcription of cytochrome P450 genes. J Biol Chem 270: 18175-18178
8. Department of Health (1996) Republic of China: General Health Statistics. In: Health and Vital Statistics, pp. 88-111. Republic of China Press: Taipei
9. Drakoulis N, Cascorbi I, Brockmoller J, Gross CR and Roots I (1994) Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer. Clin Invest 72: 240-248
10. Gallagher J, Mumford J, Li X, Shank T, Manchester D and Lewtas J (1993) DNA Adduct Profiles and Levels in Placenta, Blood and Lung in Relation to Cigarette Smoking and Smoky Coal Emissions, pp. 283-292. IARC Scientific Publication no. 124: IARC: Lyon
11. Gazdar AF and Minna JD (1997) Cigarettes, sex, and lung adenocarcinoma. J Natl Cancer Inst 89: 1563-1565.
12. Gielen JE, Goujon F, Sele J and Van Canfort J (1979) Organ specificity of induction of activating and inactivating enzymes by cigarette smoke and cigarette smoke condensate. Arch Toxicol 2(Suppl): 239-251
13. Hall M and Grover PL (1990) Polycyclic aromatic hydrocarbons: Metabolism, activation, and tumor initiation. In: Chemical Carcinogenesis and Mutagenesis I. Cooper CS and Grover PL (eds), pp 327-372. Springer-Verlag: Berlin
14. Hassett C, Aicher L, Sidhu JS and Omiecinski CJ (1994) Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3: 421-428
15. Hassett C, Lin J, Carty CL, Laurenzana EM and Omiecinski CJ (1997) Human hepatic microsomal epoxide hydrolase: Comparative analysis of polymorphic expression. Arch Biochem Biophys 337: 275-283
16. Hayashi S, Watanabe J, Nakachi K and Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 110: 407-411
17. Hemminki K and Pershagen G (1994) Cancer risk of air pollution: Epidemiological evidence. Environ Health Perspect 10(Suppl 4): 187-192
18. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S and Vainio H (1992) Point-mutational MspI and Ile/Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomark Prevent 1: 485-189
19. Hong YS, Chang JH, Kwon OJ, Ham YA and Choi JH (1998) Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Exp Mol Med 30: 192-198
20. 32 P-postlabelling analysis of the covalent binding of benzo[ghi]perylene to DNA in vivo and in vitro. Carcinogenesis 14: 127-133
21. Josephy PP (1997) Polycyclic aromatic hydrocarbon carcinogenesis. In: Molecular Toxicology, Josephy PD (ed), pp. 338-344. Oxford University Press: New York
22. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N and Watanabe J (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263: 131-133
23. Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi S (1993) The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14: 77-87.
24. Kellermann G, Shaw CR and Luyten-Kellerman M (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Engl J Med 289: 934-937
25. Kiyohara C, Hirohata T and Inutsuka S (1996) The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 87: 18-24
26. Kiyohara C, Nakanishi Y, Inutsuka S, Takayama K, Hara N, Motohiro A, Tanaka K, Kono S and Hirohata T (1998) The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics 8: 315-523
27. Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP and McLemore TL (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res 42: 5030-5037
28. Kuo C-Y, Chen C-Y, Cheng Y-W and Lee H (1998) Correlation between the amounts of polycyclic aromatic hydrocarbons and mutagenicity of airborne particulate samples from Taichung city, Taiwan. Environ Res 78: 43-49
29. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR and Lau AF (1998) Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58: 4858-4863
30. Lu AY and Miwa GT (1980) Molecular properties and biological functions of microsomal epoxide hydrase. Ann Rev Pharmacol Toxicol 20: 513-531
31. Mass MJ, Abu-Shakra A, Roop BC, Nelson G, Galati AJ, Stoner CD, Nesnow S and Ross JA (1996) Benzo [b]fluoranthene: Tumorigenicity in strain A/J mouse lungs, DNA adducts and mutations in the Ki-ras oncogene. Carcinogenesis 17: 1701-1704
32. Oesch F (1973) Mammalian epoxide hydrase: Inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3: 305-340
33. Omiecinski CJ, Aicher L, Holubkov R and Checkoway H (1993) Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 3: 150-158
34. Pastorelli R, Guanci M, Cerri A, Negri E, La Vecchia C, Fumagalli F, Mezzetti M, Cappelli R, Panigalli T, Fanelli R and Airoldi L (1998) Impact of inherited polymorphisms in glutathione s-transferease MI, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo[a]pyrene-diolepoxide. Cancer Epidemiol Biomark Prevent 7: 703-709
35. Pershagen G and Simonato L (1990) Epidemiological evidence on air pollution and cancer. In: Air Pollution and Human Cancer, Tomatis L (ed), pp 63-74. Springer-Verlag: Heidelberg
36. Persson I, Johansson I, Lou Y-C, Yue Q-Y, Duan L-S, Bertilsson L and Ingelman Sundberg M (1999) Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer 81: 325-329
37. Raaka S, Hassett C and Omiecinski CJ (1998) Human microsomal epoxide hydrolase: 5′-flanking region genetic polymorphisms. Carcinogenesis 19: 387-393
38. Rannug A, Alexandrie A, Persson I and Ingelman-Sundberg M (1995) Genetic polymorphism of cytochromes P4501A1, 2D6 and 2E1: Regulation and toxicological significance. J Occu Environ Med 37: 25-36
39. Shields PG, Bowman EG and Harrington AM (1993) Polycyclic aromatic hydrocarbon DNA adducts in human lung and cancer susceptibility genes. Cancer Res 53: 3486-3492
40. Smith CAD and Harrison DJ (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350: 630-633
41. Tefre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brogger A and Borresen AL (1991) Human CYP1A1 (cytochrome P1450) gene: Lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1: 20-25
42. Witschi H, Espiritu I, Maronpot RR, Pinkerton KE and Jones AD (1997) The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis 18: 2035-2042
43. Xu X, Kelsey KT, Wiencke JK, Wain JC and Christiani DC (1996) Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomark. Prevent 5: 687-692